Novo Nordisk A/S NOVOb.CO:
U.S. FEDERAL TRADE COMMISSION SAYS IT HAS CONCERNS ABOUT NOVO NORDISK BID FOR METSERA - FTC LETTER TO METSERA
FTC IS CONCERNED ABOUT NOVO-METSERA DEAL PROCEEDING WITHOUT FILING FOR HART-SCOTT-RODINO ANTITRUST CLEARANCE
FTC SAYS IT HAS NO POSITION ON WHETHER THE PROPOSED NOVO-METSERA TRANSACTION ABIDES BY ANTITRUST LAW
US SAYS STRUCTURE OF NOVO NORDISK TRANSACTION MAY REDUCE METSERA'S INCENTIVE TO CONTINUE BRINGING DRUGS TO MARKET
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.